AVP and Anxiety: Previous studies have established that genetic and pharmacological interventions targeting neuropeptide systems, including corticotropin-releasing hormone (CRH), substance P, arginine vasopressin (AVP), galanin, neuropeptide Y, and their corresponding receptors, significantly modulate stress-related and anxiety-like behaviors in rodents.